Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - DECHRA PHARMACEUTICALS PLC Amend

2 Nov 2023 08:50

RNS Number : 1861S
Barclays PLC
02 November 2023
 

FORM 8.3 Amendment to Purchase

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short positions disclosed, if different from 1(a):

 

(c)

Name of offeror/offeree in relation to whose relevant securities this form relates:

DECHRA PHARMACEUTICALS PLC

(d)

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e)

Date position held/dealing undertaken:

20 Oct 2023

(f)

In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

NO

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing(if any)

Class of relevant security:

1p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1) Relevant securities owned and/or controlled:

7,618,559

6.69%

2,121,613

1.86%

(2) Cash-settled derivatives:

1,453,725

1.28%

7,519,000

6.60%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 

0

0.00%

0

0.00%

TOTAL: 

9,072,284

7.97%

9,640,613

8.46%

(b)

Rights to subscribe for new securities (including directors and other executive options)

Class of relevant security in relation to which subscription right exists

Details, including nature of the rights concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchase and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

1p ordinary

Purchase

31,891

37.8458 GBP

1p ordinary

Purchase

24,449

37.8203 GBP

1p ordinary

Purchase

21,031

37.8714 GBP

1p ordinary

Purchase

15,670

37.8400 GBP

1p ordinary

Purchase

12,834

37.8617 GBP

1p ordinary

Purchase

10,000

37.8389 GBP

1p ordinary

Purchase

5,710

37.8600 GBP

1p ordinary

Purchase

4,530

37.8549 GBP

1p ordinary

Purchase

2,323

37.8677 GBP

1p ordinary

Purchase

1,102

37.8200 GBP

1p ordinary

Purchase

1,088

37.8426 GBP

1p ordinary

Purchase

977

37.8542 GBP

1p ordinary

Purchase

913

37.8257 GBP

1p ordinary

Purchase

654

37.8260 GBP

1p ordinary

Purchase

626

37.8207 GBP

1p ordinary

Purchase

436

37.8485 GBP

1p ordinary

Purchase

302

37.8305 GBP

1p ordinary

Purchase

195

37.8300 GBP

1p ordinary

Purchase

191

37.8800 GBP

1p ordinary

Purchase

145

37.9400 GBP

1p ordinary

Sale

44,300

37.8399 GBP

1p ordinary

Sale

35,918

37.8498 GBP

1p ordinary

Sale

29,895

37.8200 GBP

1p ordinary

Sale

3,377

37.8290 GBP

1p ordinary

Sale

1,959

37.8344 GBP

1p ordinary

Sale

1,803

37.8285 GBP

1p ordinary

Sale

923

37.8274 GBP

1p ordinary

Sale

860

37.8325 GBP

1p ordinary

Sale

679

37.8251 GBP

1p ordinary

Sale

667

37.8297 GBP

1p ordinary

Sale

665

37.8213 GBP

1p ordinary

Sale

334

37.8149 GBP

1p ordinary

Sale

314

37.8600 GBP

1p ordinary

Sale

211

37.8091 GBP

1p ordinary

Sale

195

37.8300 GBP

1p ordinary

Sale

194

37.8319 GBP

1p ordinary

Sale

191

37.8800 GBP

1p ordinary

Sale

165

37.8400 GBP

1p ordinary

Sale

108

37.8562 GBP

1p ordinary

Sale

32

37.8837 GBP

(b)

Cash-settled derivative transactions

Class of relevant security

Product description

Nature of dealing

Number of reference securities

Price per unit

1p ordinary

SWAP

Long

9

37.8211 GBP

1p ordinary

CFD

Long

105

37.8548 GBP

1p ordinary

SWAP

Long

108

37.8562 GBP

1p ordinary

SWAP

Long

159

37.8800 GBP

1p ordinary

SWAP

Long

184

37.8465 GBP

1p ordinary

SWAP

Long

8,198

37.8600 GBP

1p ordinary

SWAP

Long

17,519

37.8336 GBP

1p ordinary

SWAP

Long

31,635

37.8418 GBP

1p ordinary

SWAP

Short

145

37.8830 GBP

1p ordinary

SWAP

Short

154

37.8618 GBP

1p ordinary

SWAP

Short

495

37.8430 GBP

1p ordinary

SWAP

Short

533

37.8400 GBP

1p ordinary

CFD

Short

981

37.8665 GBP

1p ordinary

SWAP

Short

3,275

37.8411 GBP

1p ordinary

CFD

Short

5,087

37.8600 GBP

1p ordinary

SWAP

Short

8,198

37.8600 GBP

1p ordinary

SWAP

Short

10,000

37.8389 GBP

1p ordinary

SWAP

Short

10,992

37.8570 GBP

1p ordinary

SWAP

Short

12,834

37.8617 GBP

1p ordinary

SWAP

Short

15,416

37.8784 GBP

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class of relevant security

Product description

Writing, purchasing, selling, varying etc

Number of securities to which option relates

Exercise price per unit

Type

Expiry date

Option money paid/ received per unit

(ii)

Exercising

 

Class of relevant security

Product description

Exercising/ exercised against

Number of securities

Exercise price per unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant security

Nature of Dealings

Details

Price per unit (if applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights of future acquisition or disposal of any relevant securities to which any derivative is referenced:

NONE

(c)

Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

02 Nov 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETDZMGMRZNGFZG
Date   Source Headline
16th Jan 20244:54 pmRNSHolding(s) in Company
16th Jan 20243:29 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20242:43 pmRNSHolding(s) in Company
16th Jan 20241:25 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:15 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:02 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
16th Jan 202412:50 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
16th Jan 202412:44 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 202412:04 pmRNSHolding(s) in Company
16th Jan 202410:15 amRNSScheme of Arrangement becomes Effective
16th Jan 202410:11 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PLC
16th Jan 202410:11 amRNSForm 8.5 (EPT/RI)
16th Jan 20249:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20249:04 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
16th Jan 20249:00 amRNSHolding(s) in Company
16th Jan 20248:12 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
16th Jan 20247:39 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
16th Jan 20247:30 amRNSSuspension - Dechra Pharmaceuticals PLC
15th Jan 20244:51 pmRNSDirector/PDMR Shareholding
15th Jan 20243:51 pmRNSHolding(s) in Company
15th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:57 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Jan 202412:35 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Jan 202412:05 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:51 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:25 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Jan 20249:58 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
15th Jan 20249:31 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
15th Jan 20249:13 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20247:29 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
12th Jan 20244:02 pmRNSCourt sanction of Scheme of Arrangement
12th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:07 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:42 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:30 pmRNSHolding(s) in Company
12th Jan 20241:38 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
12th Jan 20241:24 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202412:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202410:39 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
12th Jan 202410:39 amRNSForm 8.5 (EPT/RI)
12th Jan 202410:36 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 202410:35 amRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20249:34 amRNSHolding(s) in Company
12th Jan 20249:22 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
12th Jan 20248:09 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.